RFA-CA-25-006-Full-Announcement.html

This is a Notice of Funding Opportunity (NOFO) from the National Cancer Institute (NCI) seeking revision applications from current NCI U01 research projects to incorporate new technical approaches or devices developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program. The funding opportunity number is RFA-CA-25-006, issued under the Cancer Detection and Diagnosis Research program (CFDA 93.394).

The NOFO aims to accelerate cancer research by promoting interdisciplinary collaboration and independent validation of emerging technologies. It is open to a wide range of applicants including higher education institutions, nonprofit organizations, for-profit organizations, small businesses, tribal organizations, and various government entities. The funding will be provided through a cooperative agreement (U01) mechanism, with clinical trials being optional. The Department of Health and Human Services National Institutes of Health is the issuing agency for this opportunity.